0001375151-20-000046.txt : 20200320 0001375151-20-000046.hdr.sgml : 20200320 20200320160127 ACCESSION NUMBER: 0001375151-20-000046 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200319 FILED AS OF DATE: 20200320 DATE AS OF CHANGE: 20200320 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FARR STEPHEN J CENTRAL INDEX KEY: 0001247666 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34962 FILM NUMBER: 20731956 MAIL ADDRESS: STREET 1: SFARR@ZOGENIX.COM CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ZOGENIX, INC. CENTRAL INDEX KEY: 0001375151 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205300780 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5959 HORTON STREET, SUITE 500 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 550-8300 MAIL ADDRESS: STREET 1: 5959 HORTON STREET, SUITE 500 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: ZOGENIX INC DATE OF NAME CHANGE: 20060911 4 1 wf-form4_158473446908682.xml FORM 4 X0306 4 2020-03-19 0 0001375151 ZOGENIX, INC. ZGNX 0001247666 FARR STEPHEN J C/O ZOGENIX, INC. 5959 HORTON STREET, SUITE 500 EMERYVILLE CA 94608 1 1 0 0 President and CEO Common Stock 2020-03-19 4 S 0 6158 18.5066 D 55590 D Common Stock 2020-03-19 4 M 0 9661 10.35 A 65251 D Stock Option (Right to Buy) 10.35 2020-03-19 4 M 0 9661 0 D 2026-03-13 Common Stock 9661.0 90767 D The sale transaction reported in this Form 4 was made pursuant to a Rule 10b5-1 trading plan. Represents the weighted average sales price per share. The shares were sold at prices ranging from $17.86 to $18.83 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. The option was granted on March 14, 2016 and vests in a series of forty-eight (48) successive, equal monthly installments beginning on April 14, 2016, subject to the reporting person's continuous service to the Issuer on each vesting date. /s/ Thomas Doyle, Attorney-in-fact for Stephen Farr 2020-03-20